| 000 -LEADER |
|---|
| fixed length control field |
02212cam a22003258a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
17330052 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20141206134136.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120530s2012 stk b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2012022101 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780702042997 |
| 040 ## - CATALOGING SOURCE |
|---|
| Transcribing agency |
SA-DiMC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QV 744 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.1 |
| Edition number |
22 |
| Item number |
DRR |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Drug discovery and development / |
| Statement of responsibility, etc. |
[edited by] Raymond Hill, Humphrey Rang. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Edinburgh : |
| Name of publisher, distributor, etc. |
Elsevier, |
| Date of publication, distribution, etc. |
2013. |
| 263 ## - PROJECTED PUBLICATION DATE |
|---|
| Projected publication date |
1209 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
p. ;345 |
| Dimensions |
cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The development of the pharmaceutical industry / H.P. Rang -- The nature of disease and the purpose of therapy / H.P. Rang, R.G. Hill -- Therapeutic modalities / H.P. Rang, H. LeVine, R.G. Hill -- The drug discovery process : general principles and some case histories / H.P. Rang, R.G. Hill -- Choosing the project / H.P. Rang, R.G. Hill -- Choosing the target / H.P. Rang, R.G. Hill -- The role of information, bioinformatics and genomics / B. Robson, R. McBurney -- High-throughput screening / D. Cronk -- The role of medicinal chemistry in the drug discovery process / P. Beswick, A. Naylor -- DMPK optimization strategy in drug discovery / P.G. Ballard ... [et al.] -- Pharmacology : its role in drug discovery / H.P. Rang -- Biopharmaceuticals / H. LeVine -- Scaffolds: small globular proteins as antibody substitutes / D. Grabulovski, J. Bertschinger -- Drug development : introduction / H.P. Rang, R.G. Hill -- Assessing drug safety / H.P. Rang, R.G. Hill -- Pharmaceutical development / T. Lundqvist, S. Bredenberg -- Clinical development: present and future / C. Keywood -- Clinical imaging in drug development / P.M. Matthews -- Intellectual property in drug discovery and development / P. Grubb -- Regulatory affairs / I. Hogglof, Holmgren -- Marketing the drug? / V.L. Lawton -- Drug discovery and development : facts and figures / H.P. Rang, R.G. Hill. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drug Discovery. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Biopharmaceutics. |
| 650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Technology, Pharmaceutical. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Hill, Raymond |
| Fuller form of name |
(Raymond G.) |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Rang, H. P. |
| 901 ## - LOCAL DATA ELEMENT A, LDA (RLIN) |
|---|
| a |
930 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Books |
